Aridis Pharmaceuticals
Aridis Pharmaceuticals's email is patzere@aridispharma.com
and
Aridis Pharmaceuticals's phone number is 4089603822
.
Aridis Pharmaceuticals, Inc. discovers and develops anti-infectives to be used as add-on treatments to standard-of-care antibiotics. The Company is utilizing its proprietary ʎPEXTM and MabIgX® technology platforms to rapidly identify rare, potent antibody-producing B-cells from patients who have succ...
View Top Employees for Aridis Pharmaceuticals
|
Industry | Biotechnology |
|
Location | Los Gatos, California, United States |
|
Employees | 10 |
|
HQ | 5941 Optical Court |
|
Phone | 408-960-3822 |
|
patzere@aridispharma.com | |
|
Funding | 67,108,948 USD |
|
|
Industry | Biotechnology |
|
|
Location | Los Gatos, California, United States |
|
|
Employees | 10 |
|
linkedin.com/company/aridis-pharmaceuticals | |
|
|
HQ | 5941 Optical Court |
|
|
Phone | 408-960-3822 |
|
|
patzere@aridispharma.com | |
|
|
Funding | 67,108,948 USD |
Aridis Pharmaceuticals Questions
Where are Aridis Pharmaceuticals's headquarters?
Aridis Pharmaceuticals's headquarters are in 5941 Optical Court
What is Aridis Pharmaceuticals's phone number?
Aridis Pharmaceuticals's phone number is 4089603822
How many employees are working in Aridis Pharmaceuticals right now?
Aridis Pharmaceuticals has
10 employees.
View the Email and Phone Numbers for all 10 working at Aridis Pharmaceuticals.
What is Aridis Pharmaceuticals's industry?
Aridis Pharmaceuticals's industry is
Biotechnology
What is Aridis Pharmaceuticals's email address?
Aridis Pharmaceuticals's email address is patzere@aridispharma.com
What are Aridis Pharmaceuticals's categories?
Aridis Pharmaceuticals's categories are Biotechnology, Content Discovery, Health Care, Pharmaceutical
What is Aridis Pharmaceuticals's location?
Aridis Pharmaceuticals's location is
Los Gatos, California, United States
What is Aridis Pharmaceuticals's funding?
Aridis Pharmaceuticals's funding is 67,108,948 USD
What is Aridis Pharmaceuticals's current status?
Aridis Pharmaceuticals's current status is ipo
